Migration and function of Th17 cells in the gut

Th17 细胞在肠道中的迁移和功能

基本信息

  • 批准号:
    7882855
  • 负责人:
  • 金额:
    $ 33.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Th17 cells play important roles in immunity, tissue inflammation and autoimmune diseases. The intestine is the most Th17 cell-enriched organ in the body. Therefore, investigation into the migration and function of Th17 cells in the gut would yield important information on the functions of Th17 cells in regulation of immune responses and immune tolerance in the intestine. It is unknown how Th17 cells are induced, maintained and localized in the gut. This is a significant problem in our understanding and control of this important T cell lineage. The central hypothesis of this application is that trafficking receptors play important roles in regulation of migration, induction, and/or maintenance of Th17 cells in the intestine. Our rationale is that it will become possible to more effectively control inflammatory diseases and infection in the gut by regulating the migration, induction and maintenance of gut Th17 cells after the proposed research is completed. Among the trafficking receptors, we will focus our research on CCR6, CCR9 and 1427. CCR6 is the receptor that is characteristically expressed by most Th17 cells and binds the chemokine CCL20 specifically expressed in the inductive sites of the intestine. CCR9 is a retinoic acid-induced trafficking receptor and plays potentially important roles in Th17 cell migration to certain effector sites of the intestine. 1427 is another retinoic-induced receptor potentially important for migration of Th17 cells to both inductive and effector sites. It is likely that the three receptors cooperatively regulate subset-specific distribution of Th17 cells in various anatomic compartments of the intestine. There are three aims: Specific aim #1. Determine the mechanism for coordinated regulation of the expression and/or activity of CCR6, CCR9 and 1427 in Th17 cells. Specific aim #2. Determine the individual and coordinated roles of CCR6, CCR9 and 1427 in Th17 cell migration to various microanatomic sites within the intestine. Specific aim #3. Determine the roles of CCR6, CCR9 and 1427 in induction, maintenance and effector function of Th17 cells in the gut. It is expected to yield novel knowledge regarding the trafficking receptor requirement for migration, induction and maintenance of gut Th17 cells. The project will also provide novel strategies to control the migration of Th17 cells and their differentiation and activities in specific anatomic sites of the gut. This problem has primary importance to the inflammatory pathology and infection associated with the gut (e.g. inflammatory bowel diseases and infection) but is important also for inflammatory diseases in other tissue sites as well. PUBLIC HEALTH RELEVANCE: Th17 cells have recently been recognized as a major lineage of immune cells that regulate inflammation in the body. The research aims to provide novel strategies to control the migration, differentiation and function of Th17 cells in the intestine, which are particularly relevant to inflammatory bowel diseases. The outcomes can also be applied to control of Th17-cell-regulated inflammation and immunity in other tissues.
描述(申请人提供):Th 17细胞在免疫、组织炎症和自身免疫性疾病中发挥重要作用。肠道是体内Th 17细胞最丰富的器官。因此,对肠道中Th 17细胞的迁移和功能的研究将产生关于Th 17细胞在肠道中调节免疫应答和免疫耐受的功能的重要信息。目前尚不清楚Th 17细胞如何在肠道中诱导、维持和定位。这是我们理解和控制这一重要T细胞谱系的一个重要问题。本申请的中心假设是运输受体在调节肠中Th 17细胞的迁移、诱导和/或维持中起重要作用。我们的理由是,在拟议的研究完成后,通过调节肠道Th 17细胞的迁移、诱导和维持,将有可能更有效地控制肠道炎症性疾病和感染。在转运受体中,我们将重点研究CCR 6、CCR 9和1427。CCR 6是由大多数Th 17细胞特征性表达的受体,并结合在肠的诱导位点特异性表达的趋化因子CCL 20。CCR 9是一种视黄酸诱导的转运受体,在Th 17细胞向肠道某些效应位点的迁移中起着潜在的重要作用。1427是另一种视黄酸诱导的受体,对Th 17细胞迁移到诱导和效应位点可能很重要。这是可能的,这三种受体协同调节亚群特异性分布的Th 17细胞在肠道的各种解剖隔室。有三个目标:具体目标#1。确定协调调节Th 17细胞中CCR 6、CCR 9和1427的表达和/或活性的机制。具体目标#2确定CCR 6,CCR 9和1427在Th 17细胞迁移到肠道内各种微解剖部位中的单独和协调作用。具体目标#3确定CCR 6、CCR 9和1427在肠道Th 17细胞的诱导、维持和效应功能中的作用。预计将产生新的知识,运输受体的迁移,诱导和维持肠道Th 17细胞的要求。该项目还将提供新的策略来控制Th 17细胞的迁移及其在肠道特定解剖部位的分化和活动。该问题对于与肠道相关的炎性病理学和感染(例如炎性肠病和感染)具有首要重要性,但对于其他组织部位的炎性疾病也是重要的。 公共卫生相关性:Th 17细胞最近被认为是调节体内炎症的免疫细胞的主要谱系。该研究旨在提供新的策略来控制肠道中Th 17细胞的迁移,分化和功能,这与炎症性肠病特别相关。这些结果也可以应用于控制其他组织中Th 17细胞调节的炎症和免疫。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHANG H KIM其他文献

CHANG H KIM的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHANG H KIM', 18)}}的其他基金

Mobilization and trafficking of central ILC progenitors
中央 ILC 祖细胞的动员和贩运
  • 批准号:
    10766537
  • 财政年份:
    2023
  • 资助金额:
    $ 33.55万
  • 项目类别:
Mobilization and trafficking of central ILC progenitors
中央 ILC 祖细胞的动员和贩运
  • 批准号:
    10732869
  • 财政年份:
    2023
  • 资助金额:
    $ 33.55万
  • 项目类别:
Regulation of the development of dendritic cells in barrier tissues by retinoid gradients
通过类维生素A梯度调节屏障组织中树突状细胞的发育
  • 批准号:
    10092940
  • 财政年份:
    2020
  • 资助金额:
    $ 33.55万
  • 项目类别:
Homing of Functionally Distinct ILC Subsets
功能不同的 ILC 子集的归位
  • 批准号:
    9228316
  • 财政年份:
    2016
  • 资助金额:
    $ 33.55万
  • 项目类别:
A multiphoton confocal microscope for biomedical research at Purdue University
普渡大学用于生物医学研究的多光子共焦显微镜
  • 批准号:
    7813549
  • 财政年份:
    2010
  • 资助金额:
    $ 33.55万
  • 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
  • 批准号:
    8501249
  • 财政年份:
    2010
  • 资助金额:
    $ 33.55万
  • 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
  • 批准号:
    8115882
  • 财政年份:
    2010
  • 资助金额:
    $ 33.55万
  • 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
  • 批准号:
    8306171
  • 财政年份:
    2010
  • 资助金额:
    $ 33.55万
  • 项目类别:
Migration and function of Th17 cells in the gut
Th17 细胞在肠道中的迁移和功能
  • 批准号:
    7930000
  • 财政年份:
    2009
  • 资助金额:
    $ 33.55万
  • 项目类别:
Therapeutic delivery of FoxP3+ T cells to the intestine
将 FoxP3 T 细胞治疗性递送至肠道
  • 批准号:
    8230608
  • 财政年份:
    2008
  • 资助金额:
    $ 33.55万
  • 项目类别:

相似海外基金

Delivery of actives to anatomic sites
将活性物质递送至解剖部位
  • 批准号:
    2451643
  • 财政年份:
    2020
  • 资助金额:
    $ 33.55万
  • 项目类别:
    Studentship
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    9549658
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    8938270
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    10263773
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    9154222
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    8349600
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    10919003
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    8565464
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    8763651
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
HPV and cancer at multiple anatomic sites
多个解剖部位的 HPV 和癌症
  • 批准号:
    8157952
  • 财政年份:
  • 资助金额:
    $ 33.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了